Age at diagnosis, skin color, marriage status, tobacco smoking, alcohol consumption, comorbidity, second primary site cancer, family history of cancer, and the number of relatives with cancer. Tumor size, clinical stage at diagnosis, histological type, nodal status, and grade. Estrogen receptor expression, progesterone receptor expression, HER2 Neu status, and the type of treatment. This evidence concerns the gene ERBB2 and cancer.